Ajulemic acid, a synthetic cannabinoid, increases formation of the endogenous proresolving and anti-inflammatory eicosanoid, lipoxin A4.

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
Robert B ZurierC N Serhan

Abstract

Ajulemic acid (AjA), a synthetic nonpsychoactive cannabinoid, and lipoxin A(4) (LXA(4)), an eicosanoid formed from sequential actions of 5- and 15-lipoxygenases (LOX), facilitate resolution of inflammation. The purpose of this study was to determine whether the ability of AjA to limit the progress of inflammation might relate to an increase in LXA(4), a known anti-inflammatory and proresolving mediator. Addition of AjA (0-30 microM) in vitro to human blood and synovial cells increased production of LXA(4) (ELISA) 2- to 5-fold. Administration of AjA to mice with peritonitis resulted in a 25-75% reduction of cells invading the peritoneum, and a 7-fold increase in LXA(4) identified by mass spectrometry. Blockade of 12/15 LOX, which leads to LXA(4) synthesis via 15-HETE production, reduced (>90%) the ability of AjA to enhance production of LXA(4) in vitro. These results suggest that AjA and other agents that increase endogenous compounds that facilitate resolution of inflammation may be useful for conditions characterized by inflammation and tissue injury.

References

May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·K F BadrC N Serhan
Jan 1, 1989·Arthritis and Rheumatism·S B Abramson, G Weissmann
Dec 15, 1988·Biochemical and Biophysical Research Communications·C EdeniusJ A Lindgren
Nov 1, 1973·Journal of Medicinal Chemistry·B LoevP J Fowler
Sep 15, 1994·Biochemical Pharmacology·S BursteinA Subramanian
Dec 31, 1998·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·M R ClarksonH R Brady
Jul 21, 2000·Current Pharmaceutical Design·S H Burstein
Jun 20, 2001·The Journal of Clinical Investigation·C N Serhan, E Oliw
Jan 18, 2003·Journal of Cellular Biochemistry·Robert B Zurier
May 29, 2003·Methods in Molecular Biology·Mauro Perretti, Stephen J Getting
Oct 2, 2003·JAMA : the Journal of the American Medical Association·Matthias KarstUdo Schneider
Mar 23, 2004·Journal of the American Society of Nephrology : JASN·Takamoto OhseMasaomi Nangaku
Jun 24, 2005·The New England Journal of Medicine·Nancy J Olsen
Aug 30, 2005·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Nan ChiangCharles N Serhan
Jun 6, 2006·Current Opinion in Pharmacology·Jan M Schwab, Charles N Serhan
Jul 4, 2006·Progress in Lipid Research·Moumita GhoshChristina C Leslie
Aug 24, 2006·Journal of Cellular Biochemistry·David R JohnsonRobert B Zurier
Feb 3, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Charles N SerhanJohn L Wallace
Apr 6, 2007·International Journal of Experimental Pathology·Toby Lawrence, Derek W Gilroy
Oct 19, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Shannon Reagan-ShawNihal Ahmad
Nov 28, 2007·Rheumatology International·Jennifer ParkerRobert B Zurier

❮ Previous
Next ❯

Citations

Nov 15, 2012·Proceedings of the National Academy of Sciences of the United States of America·Fabricio A PamplonaReinaldo N Takahashi
Feb 10, 2009·The AAPS Journal·Sumner H Burstein, Robert B Zurier
Apr 16, 2014·Bioorganic & Medicinal Chemistry·Sumner H Burstein
Sep 6, 2010·Pharmaceuticals·Aoife GowranVeronica Campbell
Jun 19, 2012·Trends in Endocrinology and Metabolism : TEM·Walter Wahli, Liliane Michalik
Dec 29, 2009·Neuroscience Letters·Fabrício A PamplonaReinaldo N Takahashi
Jul 7, 2009·Pharmacology & Therapeutics·Andrea Huwiler, Josef Pfeilschifter
Sep 30, 2009·British Journal of Pharmacology·Paola Maderna, Catherine Godson
Dec 17, 2014·Pharmacology Research & Perspectives·Sumner H Burstein, Mark A Tepper
Jul 7, 2015·Annals of the American Thoracic Society·Theodore J TorphyUNKNOWN Antiinflammatory Therapy Working Group
Apr 12, 2018·Pharmacology Research & Perspectives·Sumner H Burstein
Dec 15, 2017·Clinical Pharmacology and Therapeutics·Madhur P MotwaniDerek W Gilroy
Oct 31, 2018·Cellular and Molecular Life Sciences : CMLS·Catherine DongVenkatesh L Hegde
Sep 14, 2019·Future Medicinal Chemistry·Francesca GadoClementina Manera
Jul 4, 2019·Clinical Reviews in Allergy & Immunology·Fereshte AbdolmalekiAmirhossein Sahebkar
Nov 3, 2016·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Robert B Zurier, Sumner H Burstein
Sep 19, 2019·Expert Review of Respiratory Medicine·Oliver J McElvaneyNoel G McElvaney
Sep 29, 2020·Frontiers in Pharmacology·Maelle BriottetValerie Urbach
Aug 28, 2020·Frontiers in Pharmacology·Antonio RecchiutiMario Romano
Nov 27, 2020·Molecular Pharmacology·Sumner Burstein
Oct 5, 2020·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·James F ChmielUNKNOWN Lenabasum JBT101-CF-001 Study Group
Feb 11, 2021·Toxins·Zeinab BreijyehLaura Scrano
Nov 8, 2017·Molecular Immunology·Osk U U AnuforoJona Freysdottir
Jun 19, 2021·European Journal of Drug Metabolism and Pharmacokinetics·Qiang FuSergei P Atamas
Sep 21, 2021·Neuropathology and Applied Neurobiology·Marta TiberiValerio Chiurchiù

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here